Interestingly, it was recently shown that HMGB1 released from lymphoma, breast, and colon tumor cells enhances tumor regression induced by standard chemotherapeutic agents by activating TLR4 [9]. The gene discussed is HMGB1; the disease is colonic neoplasm.